申请人:TAKEDA PHARMACEUTICAL COMPANY LIMITED
公开号:US20210106607A1
公开(公告)日:2021-04-15
The present disclosure provides a compound having a STING agonistic activity, which may be expected to be useful as an agent for the prophylaxis or treatment of STING-related diseases.
The present disclosure relates to a compound represented by the formula (I):
wherein each symbol is as defined in the description, or a salt thereof.